Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/ACNISDIN 40 MG CAPSULAS BLANDAS

Approved

STANDARD

ACNISDIN 40 MG CAPSULAS BLANDAS

Isdin S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 3, 2021
Approval ID: 83b4d51484fbe05a
Company: Isdin S.A.
Type: Standard

Approval Details

Approval Id: 83b4d51484fbe05a
Drug Cima Aemps Name: ACNISDIN 40 MG CAPSULAS BLANDAS
Register Number: 85748
Holder Company Name: Isdin S.A.
Marketing Company Name: Isdin S.A.
Holder Company Detail Path: /organization/isdin-sa
Marketing Company Detail Path: /organization/isdin-sa
Authorization Date: 2021-02-03
Dosage Form: CÁPSULA BLANDA
Dose: 40 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Isdin S.A.
Company Detail Path: /organization/isdin-sa

Company Information

Pharmaceutical Company Name: ISDIN SA
Country Name: Spain
City Name: barcelona,barcelona,country_es
Address: CALLE PROVENÇALS, 33 - BAJO
Website: http://www.isdin.com

Active Ingredients

ISOTRETINOINA

40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 3, 2021

Approval ID

83b4d51484fbe05a

Type

Standard

Back to CIMA-AEMPS Approvals

ACNISDIN 40 MG CAPSULAS BLANDAS - CIMA-AEMPS Drug Approval Details